Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Benjamin Smith (New York, United States of America), Benjamin Smith, Eric Hoffman, Eugene Bleecker, Russell Bowler, Chris Cooper, David Couper, Alejandro Comellas, Mark Dransfield, Han MeiLan, Nadia Hansel, Jerry Krishnan, Fernando Martinez, Robert Paine, Stephen Rennard, Prescott Woodruff, R. Graham Barr. LATE-BREAKING ABSTRACT: A large airway phenotype among symptomatic smokers with preserved pulmonary function: The subpopulations and intermediate outcome measures in COPD study (SPIROMICS). Eur Respir J 2016; 48: Suppl. 60, 3829

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Clinical characteristics of four endophenotypic clusters of smokers with preserved lung function Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016 LATE-BREAKING ABSTRACT: Activity limitation and exacerbations in smokers with emphysema on CT but preserved pulmonary function. SPIROMICS Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 LATE-BREAKING ABSTRACT: Predictors of lung function decline in a cohort of subjects with severe asthma Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015 LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 LATE-BREAKING ABSTRACT: Large differences in rate of reported and unreported COPD exacerbations in Japanese patients; data from the COSMOS-J trial Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 LATE-BREAKING ABSTRACT: The prevalence of night and morning symptoms in primary care COPD patients: How do they relate to COPD health status and disease severity? An UNLOCK study Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 LATE-BREAKING ABSTRACT: Treating the most diseased segments in patients with severe emphysema: 6 month results from the STEP-UP randomized controlled trial (RCT) Source: International Congress 2015 – Advances in therapeutic bronchoscopy Year: 2015 Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 LATE-BREAKING ABSTRACT: The correlations of automated lung emphysema analysis software results with pulmonary function test Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: Plasma MMP-9 is related to a bronchitic COPD phenotype–report from the obstructive lung disease in northern Sweden (OLIN) studies Source: Annual Congress 2013 –Epidemiology of respiratory disease Year: 2013 LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: A useful physiological marker for evaluating the effect of indacaterol in COPD patients. Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 LATE-BREAKING ABSTRACT: Five items from the CAT questionnaire identify smokers with preserved lung function at higher risk for poor respiratory outcomes: An analysis of the SPIROMICS cohort Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 LATE-BREAKING ABSTRACT: Intra-day symptoms fluctuations: STORICO, observational study on the characterization of 24-hour symptoms in COPD patients Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Prediction of exercise capacity using impulse oscillation system in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013